Data Monitoring Committee (DMC)
What a definition is not
A definition is SPEQ’s plain-language decode of how a term is used in practice, cited to the documents that define it. It is a practitioner reference, not legal or regulatory advice, it does not replace the definition in the source, and where a regulator’s wording differs the regulator’s wording governs.
An independent group of experts, external to the trial’s sponsor and investigators, that periodically reviews accumulating unblinded safety and, where applicable, efficacy data to recommend whether a trial should continue as planned, be modified, or be stopped. Its independence protects the trial’s scientific and ethical integrity from being influenced by interim results.
Also called a Data Safety Monitoring Board (DSMB), the committee operates under a pre-specified charter that defines its composition, meeting cadence, the data it will review, and any statistical stopping boundaries it will apply.
A firewall separates the DMC from the sponsor and site study team: the committee sees unblinded interim data that everyone still running the trial remains blinded to, which is precisely what allows an interim look without compromising the trial’s scientific validity.
DMCs are particularly common in long-duration, event-driven, or higher-risk trials, where an early, unfavorable safety or futility signal would make continuing the trial unethical or scientifically pointless.
- —Also referred to as a Data Safety Monitoring Board (DSMB); operates under a pre-specified charter.
- —Reviews unblinded interim data that the sponsor and site staff remain blinded to, preserving trial integrity.
- —Can recommend continuation, protocol modification, or early stopping for safety, futility, or overwhelming efficacy.
- —Particularly used in long-duration, high-risk, or event-driven trials with pre-specified interim analyses.
ICH E6(R3) GCP; FDA guidance, Establishment and Operation of Clinical Trial Data Monitoring Committees (2006); ICH E9 Statistical Principles for Clinical Trials
Frequently asked questions
What is Data Monitoring Committee (DMC)?
An independent group of experts, external to the trial’s sponsor and investigators, that periodically reviews accumulating unblinded safety and, where applicable, efficacy data to recommend whether a trial should continue as planned, be modified, or be stopped. Its independence protects the trial’s scientific and ethical integrity from being influenced by interim results.
Which regulations cover Data Monitoring Committee (DMC)?
ICH E6(R3) GCP; FDA guidance, Establishment and Operation of Clinical Trial Data Monitoring Committees (2006); ICH E9 Statistical Principles for Clinical Trials